AViTA Corporation (TPEX:4735)
Taiwan · Delayed Price · Currency is TWD 30.80
-0.10 (-0.32%)
May 29, 2026, 1:30 PM CST
AViTA Revenue
AViTA had revenue of 214.87M TWD in the quarter ending March 31, 2026, with 8.23% growth. This brings the company's revenue in the last twelve months to 952.73M, up 2.37% year-over-year. In the year 2025, AViTA had annual revenue of 936.39M with 0.98% growth.
Revenue (ttm)
952.73M
Revenue Growth
+2.37%
P/S Ratio
1.24
Revenue / Employee
11.34M
Employees
84
Market Cap
1.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 936.39M | 9.09M | 0.98% |
| Dec 31, 2024 | 927.30M | 48.22M | 5.48% |
| Dec 31, 2023 | 879.08M | -321.84M | -26.80% |
| Dec 31, 2022 | 1.20B | -1.12B | -48.35% |
| Dec 31, 2021 | 2.33B | -274.96M | -10.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rossmax International | 3.81B |
| Cowealth Medical Holding | 2.86B |
| Bioptik Technology Incorporation | 865.76M |
| Diamond Biotechnology | 501.49M |
| Radiant Innovation | 389.45M |
| Wiltrom | 312.43M |
| Taiwan Biomaterial | 179.17M |
| S&S Healthcare Holding | 178.00M |